IN2014CN04222A - - Google Patents
Info
- Publication number
- IN2014CN04222A IN2014CN04222A IN4222CHN2014A IN2014CN04222A IN 2014CN04222 A IN2014CN04222 A IN 2014CN04222A IN 4222CHN2014 A IN4222CHN2014 A IN 4222CHN2014A IN 2014CN04222 A IN2014CN04222 A IN 2014CN04222A
- Authority
- IN
- India
- Prior art keywords
- present
- therapeutic agent
- phosphatidic acid
- joint diseases
- destruction
- Prior art date
Links
- 208000012659 Joint disease Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- PUPWWTUVIZOPTB-KTKRTIGZSA-N (2-hydroxy-2-oxo-1,2$l^{5}-oxaphospholan-4-yl)methyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC1COP(O)(=O)C1 PUPWWTUVIZOPTB-KTKRTIGZSA-N 0.000 abstract 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000001188 articular cartilage Anatomy 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011247047 | 2011-11-11 | ||
| PCT/JP2012/076478 WO2013069404A1 (ja) | 2011-11-11 | 2012-10-12 | 関節症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04222A true IN2014CN04222A (enExample) | 2015-07-17 |
Family
ID=48289788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4222CHN2014 IN2014CN04222A (enExample) | 2011-11-11 | 2012-10-12 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9085593B2 (enExample) |
| EP (1) | EP2803359B1 (enExample) |
| JP (1) | JP5465815B2 (enExample) |
| KR (1) | KR101953181B1 (enExample) |
| CN (1) | CN103906519B (enExample) |
| AU (1) | AU2012337087B2 (enExample) |
| BR (1) | BR112014011315B8 (enExample) |
| CA (1) | CA2855660C (enExample) |
| ES (1) | ES2634008T3 (enExample) |
| IN (1) | IN2014CN04222A (enExample) |
| MY (1) | MY168931A (enExample) |
| PH (1) | PH12014501058B1 (enExample) |
| RU (1) | RU2646457C2 (enExample) |
| SG (1) | SG11201402226PA (enExample) |
| WO (1) | WO2013069404A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2884041T3 (es) | 2014-08-12 | 2021-12-10 | Otsuka Chemical Co Ltd | Cristal de sal sódica de ácido fosfónico cíclico y método para fabricar el mismo |
| JP6727596B1 (ja) | 2019-11-22 | 2020-07-22 | 国立大学法人お茶の水女子大学 | カルバリゾホスファチジン酸 |
| JP7566783B2 (ja) | 2019-12-23 | 2024-10-15 | 大塚化学株式会社 | カルバ環状ホスファチジン酸化合物 |
| JP7736256B2 (ja) * | 2020-11-13 | 2025-09-09 | 株式会社マツモト交商 | 環状ホスファチジン酸含有組成物及び美容方法 |
| JPWO2022114058A1 (enExample) | 2020-11-26 | 2022-06-02 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2700350B2 (ja) | 1990-04-20 | 1998-01-21 | 小糸工業株式会社 | 車両感知器 |
| JP3195833B2 (ja) | 1991-09-30 | 2001-08-06 | きみ子 室伏 | 新規生理活性物質及びその製造法 |
| JPH07149772A (ja) | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素ｃの活性促進剤 |
| JPH07258278A (ja) | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | １−Ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするＤＮＡポリメラーゼαの阻害剤 |
| JPH0925235A (ja) | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | １−ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
| JP2001178489A (ja) | 1999-12-24 | 2001-07-03 | Kimiko Murofushi | 環状ホスファチジン酸の製造法 |
| JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤 |
| JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
| JP4163007B2 (ja) * | 2001-05-21 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体を含む癌転移抑制剤 |
| JP4162927B2 (ja) * | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
| RU2240131C1 (ru) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Средство "артровит" для профилактики и лечения артритов и артрозов |
| JP2007525449A (ja) * | 2003-04-11 | 2007-09-06 | ザ ユニバーシティー オブ テネシー リサーチ ファウンデーション | リゾホスファチジン酸アナログおよび新生内膜形成の阻害方法 |
| WO2006088837A2 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| JP5077893B2 (ja) * | 2006-12-28 | 2012-11-21 | 国立大学法人お茶の水女子大学 | 環状ホスファチジン酸誘導体を含む鎮痛剤 |
| JP2010189315A (ja) | 2009-02-18 | 2010-09-02 | Unitika Ltd | 関節軟骨損傷治癒促進剤及びそれを含有する飲食品 |
-
2012
- 2012-10-12 ES ES12847890.6T patent/ES2634008T3/es active Active
- 2012-10-12 EP EP12847890.6A patent/EP2803359B1/en active Active
- 2012-10-12 WO PCT/JP2012/076478 patent/WO2013069404A1/ja not_active Ceased
- 2012-10-12 KR KR1020147015608A patent/KR101953181B1/ko active Active
- 2012-10-12 JP JP2013542900A patent/JP5465815B2/ja active Active
- 2012-10-12 IN IN4222CHN2014 patent/IN2014CN04222A/en unknown
- 2012-10-12 CA CA2855660A patent/CA2855660C/en active Active
- 2012-10-12 RU RU2014123690A patent/RU2646457C2/ru active
- 2012-10-12 SG SG11201402226PA patent/SG11201402226PA/en unknown
- 2012-10-12 PH PH1/2014/501058A patent/PH12014501058B1/en unknown
- 2012-10-12 AU AU2012337087A patent/AU2012337087B2/en active Active
- 2012-10-12 US US14/357,089 patent/US9085593B2/en active Active
- 2012-10-12 BR BR112014011315A patent/BR112014011315B8/pt active IP Right Grant
- 2012-10-12 MY MYPI2014701211A patent/MY168931A/en unknown
- 2012-10-12 CN CN201280055135.7A patent/CN103906519B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2803359A1 (en) | 2014-11-19 |
| CA2855660A1 (en) | 2013-05-16 |
| US9085593B2 (en) | 2015-07-21 |
| US20140309194A1 (en) | 2014-10-16 |
| BR112014011315A2 (pt) | 2017-05-09 |
| RU2646457C2 (ru) | 2018-03-05 |
| HK1199406A1 (en) | 2015-07-03 |
| CA2855660C (en) | 2019-04-16 |
| BR112014011315B8 (pt) | 2020-09-15 |
| RU2014123690A (ru) | 2015-12-20 |
| NZ624870A (en) | 2016-01-29 |
| PH12014501058B1 (en) | 2019-11-08 |
| MY168931A (en) | 2019-01-09 |
| EP2803359A4 (en) | 2015-12-16 |
| BR112014011315B1 (pt) | 2020-03-03 |
| KR20140098778A (ko) | 2014-08-08 |
| PH12014501058A1 (en) | 2014-06-23 |
| EP2803359B1 (en) | 2017-04-19 |
| WO2013069404A1 (ja) | 2013-05-16 |
| AU2012337087A1 (en) | 2014-06-05 |
| KR101953181B1 (ko) | 2019-02-28 |
| AU2012337087B2 (en) | 2016-11-17 |
| JP5465815B2 (ja) | 2014-04-09 |
| CN103906519A (zh) | 2014-07-02 |
| ES2634008T3 (es) | 2017-09-26 |
| SG11201402226PA (en) | 2014-10-30 |
| CN103906519B (zh) | 2017-10-10 |
| JPWO2013069404A1 (ja) | 2015-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501404A1 (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
| PE20151727A1 (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c | |
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| IN2012DN06720A (enExample) | ||
| TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
| PH12014500468A1 (en) | Heterocyclic compounds and uses thereof | |
| MY163083A (en) | Solid forms of a pharmaceutically active substance | |
| CR20140567A (es) | Formulaciones y métodos para la administración vaginal de antiprogestinas | |
| MX373851B (es) | Métodos de administración de tratamiento con pirfenidona. | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| GEP201706621B (en) | Benzamides | |
| IN2015DN01151A (enExample) | ||
| MX364220B (es) | Metodos de tratamientos de fibrosis. | |
| PH12014501545A1 (en) | Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof | |
| MX2016000480A (es) | Composiciones farmaceuticas de pancreatina de alta potencia. | |
| MY173491A (en) | Therapeutic or prophylactic agent for biliary tract diseases | |
| IN2014CN04222A (enExample) | ||
| MX336333B (es) | Nueva forma cristalina de un derivado de ciclopropilbenzamida. | |
| BR112015011693A2 (pt) | composições fibrinolíticas compreendendo bromelina e nattokinase para a prevenção e tratamento de estados flebotrombóticos | |
| IN2014DN03010A (enExample) | ||
| MX2015007945A (es) | Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas. | |
| IN2014CN04119A (enExample) | ||
| TR201200215A2 (tr) | Geliştirilmiş farmasötik formülasyonlar. | |
| TR201200212A2 (tr) | Risedronat içeren geliştirilmiş formülasyonlar. | |
| UA42862U (uk) | ЗАСТОСУВАННЯ М'ЯКОЇ ЛІКАРСЬКОЇ ФОРМИ, ЯКА МІСТИТЬ АКТИВНУ РЕЧОВИНУ β-ФЕНІЛЕТИЛАМІД 2-ОКСИСУКЦИНАНІЛОВОЇ КИСЛОТИ, ДЛЯ ЛІКУВАННЯ ОПІКОВИХ УРАЖЕНЬ ШКІРИ |